R Nu6-1230P: A Potential Drug Target or Biomarker (G106481944)

Target Name: RNU6-1230P

NCBI ID: G106481944

RNU6-1230P

Other Name(s): RNA, U6 small nuclear 1230, pseudogene | U6 small nuclear 1230, pseudogene

R Nu6-1230P: A Potential Drug Target or Biomarker

RNA-U6 small nuclear 1230 (R Nu6-1230P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is derived from the small nuclear RNA (snRNA) family and is expressed in various tissues and cells, including brain, heart, and muscle.

R Nu6-1230P is characterized by its unique structure, which consists of a single RNA molecule approximately 200 nucleotides in length. The molecule has a partial double-stranded structure and is composed of a 5'-end that is composed of a single base pair and a 3'-end that is composed of a single base pair and a double base pair.

One of the unique features of R Nu6-1230P is its ability to interact with small nucleolar RNA (snRNA) molecules, which are a type of RNA molecule that plays a critical role in regulating gene expression in eukaryotic cells. These interactions between R Nu6-1230P and snRNA molecules have been shown to promote the formation of RNA-protein aggregates, which are thought to play a key role in the regulation of cellular processes.

In addition to its potential role in regulating gene expression, R Nu6-1230P has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that R Nu6-1230P is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This overexpression has been shown to promote the growth and survival of cancer cells, highlighting the potential importance of R Nu6-1230P as a drug target or biomarker.

Another potential mechanism by which R Nu6-1230P may be involved in the development and progression of cancer is its ability to interact with the protein encoded by the gene U6. U6 is a small nuclear RNA molecule that plays a critical role in regulating gene expression and is expressed in various tissues and cells, including brain, heart, and muscle.

Research has shown that R Nu6-1230P and U6 can interact with each other and that this interaction may play a role in the regulation of cellular processes. For example, studies have shown that the interaction between R Nu6-1230P and U6 can promote the formation of RNA-protein aggregates, which may play a key role in the regulation of gene expression.

In conclusion, R Nu6-1230P is a unique and highly conserved non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and ability to interact with small nucleolar RNA and U6, as well as its overexpression in various types of cancer, make it an attractive candidate for further investigation. Further studies are needed to fully understand the role of R Nu6-1230P in the regulation of gene expression and its potential as a drug target or biomarker.

Protein Name: RNA, U6 Small Nuclear 1230, Pseudogene

The "RNU6-1230P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-1230P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets